enVVeno Medical (NVNO) Return on Equity (2018 - 2020)

enVVeno Medical has reported Return on Equity over the past 3 years, most recently at 2.82% for Q3 2020.

  • Quarterly results put Return on Equity at 2.82% for Q3 2020, down 96.0% from a year ago — trailing twelve months through Sep 2020 was 2.82% (down 96.0% YoY), and the annual figure for FY2019 was 5.07%, down 680.0%.
  • Return on Equity for Q3 2020 was 2.82% at enVVeno Medical, up from 40.51% in the prior quarter.
  • Over the last five years, Return on Equity for NVNO hit a ceiling of 1.49% in Q2 2018 and a floor of 40.51% in Q2 2020.
  • Median Return on Equity over the past 3 years was 2.82% (2018), compared with a mean of 6.58%.
  • Biggest five-year swings in Return on Equity: increased 10bps in 2019 and later plummeted -3870bps in 2020.
  • enVVeno Medical's Return on Equity stood at 2.82% in 2018, then crashed by -34bps to 3.77% in 2019, then rose by 25bps to 2.82% in 2020.
  • The last three reported values for Return on Equity were 2.82% (Q3 2020), 40.51% (Q2 2020), and 15.59% (Q1 2020) per Business Quant data.